Swiss Health Care International (SHCI)
Swiss Health Care International (SHCI) was founded by a group of international working experts in Medicine, Healthcare & Management in Health, who share one mission: helping people with uncertain, serious and rare illnesses by delivering personalized Healthcare Management solutions and worldwide access to high quality, evidence -, and as well, science based medical treatments.
SERVICES & SOLUTIONS
Swiss Health Care International (SHCI) offers services & solutions for international patients in:
Swiss Health Care International (SHCI) offers services & solutions for international companies in:
Areas of Expertise
The Swiss Health Care International (SHCI) internal medical team with its scientific committee and specialists is able to have an olistic view of the speciality and so to give to the patient a complete up to date diagnostic/ therapeutical route with particular attention to innovative therapeutics options.
Three Dimensional CT Reconstruction for the Evaluation and Surgical Planning in the field of Odontology, Orthopedic and Neurology.
Kamel Khalili Neurovirologist Temple University now visiting Professor at the University of Milan
Kamel Khalili Neurovirologist Temple University is now Visiting Professor at the University of Milan. Professor Khalili is known for being the first scientist to have completely “deleted” the HIV DNA from the Human Genome by the gene editing CRISPR/CAS9 technology. This innovative technique has been published on TIME Magazine. The technology CRIPR/CAS9 is illustrated on youtube.
Reduce the incidence and mortality rates for a number of tumors with a trivial dose of aspirin every day
A new study reveals how low doses of acetylsalicylic acid – between 75 and 325 mg daily – may decrease the formation of digestive tumors up to 35% and the relative rate of deaths up to 50%. Published in the journal “Annals of Oncology”, the survey conducted in Great Britain noted that 10 years of continued use of aspirin reduces the incidence of colon cancer by 35%, and 30% of esophagus and stomach. Mortality was decreased compared to the average, between aspirin users, 40% for colon cancer by 50% for the esophagus and 35% for the stomach cancer – According to the oncologists’ Queen Mary University ‘in London, “the prophylactic use of aspirin for a minimum of five years at doses between 75 and 325 mg daily appears to produce a positive result in terms of cancer prevention. Prolonged use in all likelihood will have even more benefits “. Risults: benefits after 3 years of use, to be noted that the risks of heart attack in aspirin use concomitantly were reduced by 18%. Aspirin, however, is not without risks in fact there is a slightly increased risk of bleeding (average incidence of 2.2% to 3.6%). Jack Cuzick, first author of the study, said: “Taking aspirin every day seems to be one of the most effective tools to prevent cancer after stopping smoking and reducing obesity “. And he confessed: ” I myself take it. “
First effective vaccine in the world against chlamydia
A team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research, a structure of McMaster University in Canada, has developed the first effective vaccine in the world against chlamydia. The success came after the discovery of a new antigen that reduces the symptoms caused by the bacterium Chlamydia trachomatis, the most common cause of the disease. Chlamydia, show scientists, it is one of the most common sexually transmitted infections. In the US alone there are 2,860,000 cases annually. There are four species of bacteria that can cause infection, the most common of which is C. trachomatis. The infection, however, does not always present symptoms and, consequently, the majority of individuals unaware of being bearer. Infection with clamidya is a major cause of infertility, pelvic disease in women.
HIV Genes Have Been Cut Out of Live Animals Using CRISPR
Kamel Khalili, director of the Comprehensive NeuroAIDS Center at Temple University, report in the journal Gene Therapy that they have for the first time successfully eliminated HIV genes from the genomes of mice and rats infected with the virus.
High Tech for Peace Foundation Forum 2016 – Lugano
The Forum’s objective is to discuss on the potential of advanced technologies and scientific innovation as instruments of dialogue, coexistence, generation of common interests and, therefore, peace. The presence of international personalities of the first order in different fields has ensured the high-quality level of the Forum.The forum has been held at the Palazzo dei Congressi and has developed over two days around four themes that are among the pillars of modern society: medicine, energy, water and communications. The program has been particularly interesting thanks to a series of project presentations, discoveries and innovations that have positively influenced the lives of many people around the World, who will also benefit in the future.
Collaboration between Swiss Health Care International & Ticino Health SA
Swiss Health Care International is now partner and provider of medical consultancy & medical accompagnation for the company Ticino Health SA. Ticino Health offers for national and international clients personalized healthcare & wellness treatments in the Swiss Canton Ticino – the new Hot Spot for medical tourism in Switzerland.